微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 0.9% | -70.97% | 509.09% | 31/52 | 2.24% | 诺泰生物 | 14.63% | 行业排名> |
| 2024-03-31 | -0.22% | -112.79% | -105.15% | 37/52 | 1.22% | 澳洋健康 | 30.56% | 行业排名> |
| 2023-12-31 | 4.27% | -88.24% | -35.69% | 28/52 | 3.83% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-09-30 | 6.64% | -79.79% | 114.19% | 20/52 | 6.78% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-06-30 | 3.1% | -86.17% | 80.23% | 26/52 | 1.93% | 澳洋健康 | 61.89% | 行业排名> |
| 2023-03-31 | 1.72% | -86.35% | -95.26% | 25/52 | 2.55% | 澳洋健康 | 48.34% | 行业排名> |
| 2022-12-31 | 36.31% | -16.68% | 10.5% | 2/52 | -0.52% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-09-30 | 32.86% | -7.2% | 46.63% | 6/52 | 11.21% | *ST宜康 | 75.53% | 行业排名> |
| 2022-06-30 | 22.41% | -3.82% | 77.86% | 5/52 | 5.46% | 博腾股份 | 39.77% | 行业排名> |
| 2022-03-31 | 12.6% | -4.76% | -71.09% | 2/52 | 3.09% | 睿智医药 | 41.16% | 行业排名> |
| 2021-12-31 | 43.58% | -9.83% | 23.07% | 1/52 | -6.4% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-09-30 | 35.41% | -6.32% | 51.97% | 1/52 | 2.38% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-06-30 | 23.3% | 10.43% | 76.11% | 2/52 | 2.32% | 金域医学 | 43.58% | 行业排名> |
| 2021-03-31 | 13.23% | 536.06% | -72.63% | 1/52 | 1.85% | 金域医学 | 35.41% | 行业排名> |
| 2020-12-31 | 48.33% | 217.33% | 27.86% | 2/52 | 10.94% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-09-30 | 37.8% | 142.77% | 79.15% | 2/52 | 7.83% | 金域医学 | 13.23% | 行业排名> |
| 2020-06-30 | 21.1% | 158.9% | 914.42% | 2/52 | 2.51% | 万邦医药 | 52.05% | 行业排名> |
| 2020-03-31 | 2.08% | -5.45% | -86.34% | 9/52 | -0.22% | 华大基因 | 48.52% | 行业排名> |
| 2019-12-31 | 15.23% | 43.95% | -2.18% | 21/52 | 64.11% | 华大基因 | 31.24% | 行业排名> |
| 2019-09-30 | 15.57% | 69.06% | 91.04% | 7/52 | 10.46% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-06-30 | 8.15% | 89.1% | 270.45% | 7/52 | 5.56% | 南华生物 | 2848.07% | 行业排名> |
| 2019-03-31 | 2.2% | 300% | -79.21% | 11/52 | 3.44% | 南华生物 | 98.98% | 行业排名> |
| 2018-12-31 | 10.58% | -3.02% | 14.88% | 23/52 | -0.5% | 南华生物 | 82.46% | 行业排名> |
| 2018-09-30 | 9.21% | -26.73% | 113.69% | 12/52 | 2.84% | 南华生物 | 48.41% | 行业排名> |
| 2018-06-30 | 4.31% | -29.46% | 683.64% | 14/52 | 1.7% | 万邦医药 | 106.72% | 行业排名> |
| 2018-03-31 | 0.55% | 2% | -94.96% | 22/52 | 0.49% | 国际医学 | 46.66% | 行业排名> |
| 2017-12-31 | 10.91% | -19.84% | -13.21% | 19/52 | 2.03% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-09-30 | 12.57% | -45.16% | 105.73% | 8/52 | 8.61% | 通策医疗 | 6.02% | 行业排名> |
| 2017-06-30 | 6.11% | 2% | -55.11% | 10/52 | 58.64% | 普蕊斯 | 58.68% | 行业排名> |
| 2016-12-31 | 13.61% | -39.3% | -39.3% | 15/52 | 19.64% | 爱尔眼科 | 20.87% | 行业排名> |
| 2015-12-31 | 22.42% | 2% | -2.18% | 5/52 | 22.23% | 南华生物 | 1666.98% | 行业排名> |
| 2015-09-30 | 22.92% | 2% | 2% | 1/52 | 5.27% | 爱尔眼科 | 5.19% | 行业排名> |